NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | -61.3% | 3,000 | -72.7% | 0.02% | -50.0% |
| Q1 2019 | $680,000 | -4.9% | 11,000 | -42.1% | 0.04% | -13.6% |
| Q4 2018 | $715,000 | -20.7% | 19,000 | +21.0% | 0.04% | 0.0% |
| Q3 2018 | $902,000 | -48.6% | 15,700 | -29.6% | 0.04% | -43.6% |
| Q2 2018 | $1,755,000 | +305.3% | 22,300 | +346.0% | 0.08% | +254.5% |
| Q1 2018 | $433,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |